Eye disease - Biotech, Pharma and Life Science Channel

19:36 EDT 31st October 2014 | BioPortfolio

PubMed Articles [14535 Associated PubMed Articles listed on BioPortfolio]

Preventing and controlling zoonotic tuberculosis: a One Health approach.

The expression One Health refers to the unified human and veterinary approach to zoonoses, an approach that used to be identified with Medicine throughout the 20th Century. Zoonotic tuberculosis (TB),...

Regulation of Skeletal Muscle Development and Disease by microRNAs.

The identification of microRNAs (miRNA) in vertebrates has uncovered new mechanisms regulating skeletal muscle development and disease. miRNAs are inhibitors and act by silencing specific mRNAs or by ...

Molecular genotyping of human rhinovirus by using PCR and sanger sequencing.

Human rhinovirus (HRV) is the virus most often associated with acute upper respiratory tract infections. Advances in molecular detection have shown that HRV is also the major viral cause of asthma exa...

Classification and evolution of human rhinoviruses.

The historical classification of human rhinoviruses (RV) by serotyping has been replaced by a logical system of comparative sequencing. Given that strains must diverge within their capsid sequenced by...

Application of a novel metabolomic approach based on atmospheric pressure photoionization mass spectrometry using flow injection analysis for the study of Alzheimer׳s disease.

The use of atmospheric pressure photoionization is not widespread in metabolomics, despite its considerable potential for the simultaneous analysis of compounds with diverse polarities. This work cons...

Role of glycosaminoglycans in infectious disease.

Glycosaminoglycans (GAGs) have been shown to bind to a wide variety of microbial pathogens, including viruses, bacteria, parasites, and fungi in vitro. GAGs are thought to promote pathogenesis by faci...

Human blood glycosaminoglycans: isolation and analysis.

Glycosaminoglycans (GAGs) are linear polysaccharides having disaccharide building blocks consisting of an amino sugar (N-acetylglucosamine, or N-acetylgalactosamine) and a uronic acid (glucuronic acid...

Visuospatial impairment in Parkinson's disease: The role of laterality.

Asymmetry is one of the unique and mysterious features of Parkinson's disease (PD). Motor symptoms develop unilaterally either on the left (LPD) or the right side (RPD). Incongruent data are available...

Surgical Versus Percutaneous Revascularization in Patients with Multivessel Coronary Artery Disease.

New-generation stents have been continually developed in order to improve the safety and efficacy of percutaneous coronary intervention (PCI). Several randomized clinical trials have been conducted ov...

Second-hand Smoking and CV Risk.

Issues related to passive smoking have recently been addressed in the specialty literature, and they are particularly relevant from two perspectives: the effects on health and implications in the init...

News Articles [9906 Associated News Articles listed on BioPortfolio]

Judge rejects strict limits on nurse who treated Ebola patients

FORT KENT Maine (Reuters) - Declaring Ebola fears in the United States "not entirely rational," a judge rejected Maine's bid for a quarantine on a nurse who treated victims of the disease in West Afri...

Pentagon civilians leaving Ebola zones may choose monitoring regimen

WASHINGTON, Oct 31 (Reuters) - Civilian U.S. defense employees returning from Ebola relief work in West Africa must undergo monitoring to ensure they are free of disease but can choose between followi...

Judge rejects strict limits on U.S. nurse who treated Ebola patients

FORT KENT Maine (Reuters) - Declaring Ebola fears in the United States "not entirely rational," a judge rejected Maine's bid for a quarantine on a nurse who treated victims of the disease in West Afri...

UPDATE 2-Judge rejects strict limits on U.S. nurse who treated Ebola patients

FORT KENT, Maine, Oct 31 (Reuters) - Declaring Ebola fears in the United States "not entirely rational," a judge rejected Maine's bid for a quarantine on a nurse who treated victims of the disease in ...

CDC Releases Two New Clinical Resources in the Fight Against Ebola

To help inform U.S. healthcare workers in the fight against Ebola, the Centers for Disease Control and Prevention (CDC) has released two new resources, which are now available at http://www.cdc.gov/vh...

Infectious disease: IL-22 complements protection

Clostridium difficile infection induces the expression of interleukin-22, which regulates the complement system to eliminate systemically translocated pathobionts.

Mali Ebola victim had contact with 141 people, 57 still sought

GENEVA (Reuters) - A 2-year-old girl who brought Ebola to Mali may have had contact with as many as 141 people, 57 of whom have yet to be traced, according to health experts concerned the disease coul...

Judge enforces Ebola isolation of defiant Maine nurse

FORT KENT, Maine, Oct 31 (Reuters) - A judge on Friday ordered an American nurse who treated Ebola patients in Sierra Leone for the disease to obey a state-imposed quarantine after she defied Maine of...

Here’s a Look at What Some States Are Setting as Guidelines on Ebola Safety

(Associated Press) – States have broad authority to quarantine people to prevent the spread of disease, and several are exercising that right to go beyond the safety recommendations of the Cente...

Ebola Highlights Work of Disease Sleuths

Read more about Ebola Highlights Work of Disease Sleuths

Events [0 Results]

None

Companies [277 Associated Companies listed on BioPortfolio]

Cigna Corporation and American Heart Association

The American Heart Association is devoted to saving people from heart disease and stroke – America’s No. 1 and No. 4 killers. We team with millions of volunteers to fund...

Cardiatis S.A.

Cardiatis is a commercial stage medical technology company developing disease modifying endovascular solutions to thoracoabdominal aneurysms. Cardiatis lead product is the Cardiat...

BioPontis Alliance LLC

BioPontis Alliance for Rare Disease is a North Carolina non-profit corporation that partners with patient organizations and academic researchers to carry out the earliest stages o...

Global Virus Network (GVN)

The Global Virus Network (GVN) is an independent, not for profit organization, comprised of leading medical virologists from Argentina, Australia, Belgium, Canada, China, France, ...

Tricida, Inc.

Tricida, Inc., is a pre-clinical-stage biopharmaceutical company focused on the discovery and development of first-in-class therapeutics. Tricida’s lead program is TRC101, a ...

Catabasis Pharmaceuticals, Inc.

Catabasis Pharmaceuticals is leveraging its pathway pharmacology drug development platform to bring important medicines to patients with severe lipid disorders and rare inflammato...

BioSensics

BioSensics is a research and product development company specializing in wearable sensors for healthcare, offering innovative monitoring solutions for telehealth, aging-in-place, ...

Stemedica International S.A.

Founded in Epalinges, Switzerland, in 2008, Stemedica International S.A. is a global biotechnology company that develops therapeutic applications for the treatment and prevention ...

Shoo the Flu

The flu, also called influenza, is a contagious disease that spreads by coughing, sneezing and close contact. Flu symptoms include fever/chills, sore throat, muscle aches, fatigue...

480 Biomedical, Inc.

480 Biomedical is using the most sophisticated tools of advanced materials science to create innovative products to treat serious vascular disease and injury.

Clinical Trials [1284 Associated Clinical Trials listed on BioPortfolio]

Nocturnal Blood Pressure - Central and Peripheral 24-h Blood Pressure in Chronic Kidney Disease.

A new study have shown that high nighttime blood pressure (BP) and/or non-dipping (lack of fall in blood pressure during nighttime) is a strong predictor for the risk of cardiovascular dis...

Efficacy and Safety Study of WTX101 in Adult Wilson Disease Patients

The purpose of the study is to evaluate the efficacy and safety of WTX101 administered with a proton pump inhibitor (PPI) for 24 weeks in newly diagnosed Wilson Disease (WD) patients aged ...

Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease

Byler Disease is the result of a homozygous missense (G308V) mutation in the ATP8B1 gene. The disease is typically manifest in the first year of life on the basis of complications of chole...

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

The purpose of this study is to compare the effects of ticagrelor and clopidogrel in patients with Peripheral Artery Disease.

Exercise Interventions in Parkinson's Disease

This study sets out to determine the effect of exercise performed over a longer period of time (6 months), delivered using community facilities, on motor and non motor symptoms, health and...

A Study of RO4607381 in Patients With Coronary Heart Disease (CHD) or a CHD Risk Equivalent.

This 2 arm study will investigate the efficacy and safety of RO4607381 in patien ts with coronary heart disease, or CHD risk equivalent. After a pre-randomizatio n phase of 5-12 weeks, pat...

Voice Therapy in Parkinson Disease

The purpose of this study is to evaluate the impact of a non-invasive brain stimulation technique called transcranial magnetic stimulation (TMS) on voice/speech treatment in people with Pa...

Effect of Atorvastatin on Fractional Flow Reserve in Coronary Artery Disease

Natural course of intermediate coronary artery disease (CAD) is very important to predict the prognosis of the patient with such disease. Several studies have well demonstrated the benefi...

Study of Lu AE58054 in Patients With Mild - Moderate Alzheimer's Disease Treated With Donepezil

To establish efficacy of Lu AE58054 as adjunctive therapy to donepezil for symptomatic treatment of patients with mild-to-moderate Alzheimer's disease (AD).

Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

To assess the efficacy of rasagiline 1 mg as a first add-on treatment to dopamine agonist therapy in early Parkinson Disease (PD) patients, , not optimally controlled on dopamine agonists...

Medical and Biotech [MESH] Definitions

Animate or inanimate sources which normally harbor disease-causing organisms and thus serve as potential sources of disease outbreaks. Reservoirs are distinguished from vectors (DISEASE VECTORS) and carriers, which are agents of disease transmission rather than continuing sources of potential disease outbreaks.

Analyses for a specific enzyme activity, or of the level of a specific enzyme that is used to assess health and disease risk, for early detection of disease or disease prediction, diagnosis, and change in disease status.

The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.

Search BioPortfolio:
Loading
Advertisement
Advertisement
review and buy Eye disease market research data and corporate reports here

Channels Quicklinks